UiPath’s (PATH) Hold Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of UiPath (NYSE:PATH) in a research report sent to investors on Wednesday morning, Benzinga reports.

Other research analysts have also issued reports about the company. Wells Fargo & Company lifted their target price on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th. Morgan Stanley reiterated an “equal weight” rating and issued a $15.00 price objective on shares of UiPath in a research report on Friday, September 6th. Bank of America increased their target price on UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $16.00 price target on shares of UiPath in a research note on Friday, September 6th. Finally, Evercore ISI increased their price objective on shares of UiPath from $13.00 to $16.00 and gave the stock an “in-line” rating in a research report on Friday, September 6th. Sixteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, UiPath currently has an average rating of “Hold” and a consensus price target of $17.47.

UiPath Price Performance

Shares of PATH stock opened at $12.06 on Wednesday. The stock has a market cap of $6.91 billion, a PE ratio of -75.38 and a beta of 0.88. The stock has a 50-day moving average of $12.46 and a 200-day moving average of $14.24. UiPath has a one year low of $10.37 and a one year high of $27.87.

UiPath (NYSE:PATH) last issued its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.09) earnings per share. As a group, research analysts anticipate that UiPath will post -0.23 earnings per share for the current year.

Insider Activity

In related news, CFO Ashim Gupta sold 47,671 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the transaction, the chief financial officer now directly owns 849,917 shares in the company, valued at approximately $10,258,498.19. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 22.37% of the stock is currently owned by insiders.

Hedge Funds Weigh In On UiPath

A number of institutional investors have recently bought and sold shares of the business. ORG Partners LLC boosted its stake in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares during the period. Future Financial Wealth Managment LLC bought a new position in UiPath during the third quarter worth $26,000. JTC Employer Solutions Trustee Ltd acquired a new position in shares of UiPath in the third quarter valued at $26,000. Hantz Financial Services Inc. bought a new position in shares of UiPath in the second quarter valued at about $28,000. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in shares of UiPath by 122.5% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock worth $58,000 after buying an additional 1,407 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.